CDSCO Expert Committee Accepts Phase IV Safety Data for Eisai’s Lenvatinib Capsules
The Subject Expert Committee (SEC) under India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has accepted the Phase […]
Pharma
Amneal Pharma and mAbxience Secure USFDA Approval for Denosumab Biosimilars Boncresa and Oziltus
Amneal Pharmaceuticals and mAbxience, a majority-owned subsidiary of Fresenius Kabi with partial ownership from Insud Pharma, have received U.S. Food […]
CuraTeQ Biologics Ends Licensing Agreement With BioFactura for Ustekinumab Biosimilar
CuraTeQ Biologics Private Limited, the biologics-focused subsidiary of Aurobindo Pharma Limited, has decided to mutually terminate its licensing agreement with […]
Biocon Out-Licenses Semaglutide to Ajanta Pharma for Emerging Markets, Expanding GLP-1 Footprint
Bengaluru-headquartered Biocon Limited has entered into an out-licensing agreement with Ajanta Pharma Ltd to commercialise its GLP-1–based anti-diabetes therapy Semaglutide […]
Antimicrobial Resistance Emerges as a Silent Pandemic, Posing a Strategic Challenge for Indian Pharmaceuticals
Antimicrobial resistance (AMR) is fast becoming one of the most serious threats to modern medicine, with new global evidence showing […]
Multistage Malaria Vaccine Trial Signals New Opportunity for Next-Gen Immunisation Research
New hope for malaria-endemic regions as ProC6C vaccine demonstrates 76% efficacy in clinical trial. A novel multistage malaria vaccine, ‘ProC6C-AlOH/MM’ […]
FDA Clears Oral Version of Wegovy, Expanding Access to GLP-1 Obesity Treatments
Novo Nordisk’s daily semaglutide tablet offers an alternative to injectables as competition intensifies in the weight-loss drug market The US […]
India Introduces Minimum Import Price on Key Pharma Inputs to Strengthen Domestic Manufacturing
Policy aims to counter import dumping, enhance supply-chain security, and accelerate API self-reliance The Union Government has introduced a minimum […]
Early-Stage Nipah Virus Vaccine Trials Signal Progress in Pandemic Preparedness
Phase I results and launch of world’s first Phase II trial strengthen global efforts against a high-fatality zoonotic threat Early […]
NutriGPT: AI-Engine Enabling On-Demand, Regulatory-Ready Formulation Design for Global Pharma
A breakthrough AI tool enabling SMEs to create validated, regulatory-compliant nutraceutical formulations with enterprise-level precision. Nutrify Today, the world’s largest […]
Zydus Unveils ‘Zyrifa’: A Strategic Biosimilar that Targets Bone Health in Oncology Patients
Zydus Lifesciences Ltd., an innovation-driven global healthcare company, has announced the launch of ‘Zyrifa’, its biosimilar version of Denosumab 120 […]
Zydus, Formycon Collaborate to Bring Keytruda® Biosimilar to the US and Canada
Zydus Lifesciences has entered the North American biosimilar market with a major strategic move, announcing an exclusive partnership with Germany-based […]
AIM-NASH: First-Ever Digital Pathology Tool Approved by FDA for Liver Drug Trials
A major milestone for AI-driven drug development, the U.S. Food and Drug Administration (FDA) has officially qualified AIM-NASH, the first […]
